Furthermore, miR-328 overexpression inhibits the invasion of side population (SP) cells in the CRC and reverses drug resistance by targeting matrix metallopeptidase 16 (MMP16) and ATP-binding cassette subfamily G member 2 (ABCG2) [25, 26]. The gene discussed is MMP16; the disease is colorectal carcinoma.